Showing: 1 - 7 of 7 RESULTS
Analyst Estimate Briefing Field Trip Health Psychedelics

Eight Capital Initiates Coverage On Field Trip Health With $10.20 Price Target

Earlier this week, Eight Capital launched coverage on a basket of psychedelic companies. This comes after they produced an industry primer during the summer months. The third company on this list is Field Trip Health (CSE: FTRP) with a C$10.20 12-month price target and buy rating. Field Trip Health currently has 3 analysts covering the …

Analyst Estimate Briefing Bright Minds Biosciences Compass Pathways Cybin Inc Field Trip Health Mind Medicine Mindset Pharma Numinus Wellness Inc Psychedelics Small Pharma Inc

Psychedelics: The Eight Capital Primer

Eight Capital recently produced a primer on the psychedelic sector saying that the companies are “poised to fill a growing unmet need in mental health” and that this need has only been growing steadily but has been exacerbated by the COVID-19 pandemic. In this 27 page primer Sepehr Manochehry, their analyst, highlights COMPASS Pathways (NASDAQ: …

Atai Life Sciences Briefing Compass Pathways Field Trip Health Full Analysis Mind Cure Health Mind Medicine Psychedelics

Psychedelics & The Need For Digital Therapeutic Solutions In Treating Mental Health

In terms of investment dollar inflows, one of the largest focuses of 2020 has arguably been that of the growing need to address mental health. Thinly disguised as a focus on psychedelics to generate more excitement from investors looking to jump on the “next big thing,” the bigger picture here truly appears to be a …